PAG
UTHR icon

Private Advisor Group’s United Therapeutics UTHR Stock Holding History

Private Advisor Group’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-4,400
Closed -$9.94K – 2511
2023
Q3 		$9.94K Buy
+4,400
New +$1.01M ﹤0.01% 2176

Other funds holding UTHR

Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Retirement Systems of Alabama
Retirement Systems of Alabama Montgomery, Alabama $33.2B AUM 38.15% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
AP
Atwood & Palmer Kansas City, Missouri $1.87B AUM 24.22% 1-Year Est. Return
PCM
Polaris Capital Management Boston, Massachusetts $1.06B AUM 40.82% 1-Year Est. Return
SAM
Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
FAF
Fjarde Ap-fonden Stockholm, Sweden $20.9B AUM 36.93% 1-Year Est. Return
AIM
Achmea Investment Management Zeist, Netherlands $4B AUM 31.99% 1-Year Est. Return

Private Advisor Group's UTHR Position: Q2 2026 in Review

Private Advisor Group increased its United Therapeutics (UTHR) stake by 56% in Q2 2026, buying an estimated $280K and bringing the position to 1,388 shares worth $752K. The position accounts for ﹤0.01% of the portfolio, ranked #1526.

Private Advisor Group first reported a position in UTHR in Q3 2023 and has held it in 4 quarters since. 245 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.

  • Private Advisor Group held 1,388 shares of United Therapeutics worth $752K as of Q2 2026.
  • Private Advisor Group bought 498 United Therapeutics shares in Q2 2026, an estimated $280K.
  • United Therapeutics made up ﹤0.01% of Private Advisor Group's portfolio in Q2 2026, its #1526 holding.
  • Private Advisor Group first reported a position in United Therapeutics in Q3 2023 and has held it in 4 quarters since.
  • 245 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.

Based on Private Advisor Group's 13F filing for Q2 2026, filed 27 Jul 2026.